The Institute for Clinical and Economic Review has prepared a special report on Trelegy and Breo, two therapies that treat ...

Valued at $50 billion, the Indian pharmaceutical sector continues to grow, fueled by cost efficiency, cutting-edge ...

Venus Remedies receives marketing authorisation for Sugammadex in the Philippines, marking a major step in its expansion into complex generics and the ASEAN market. Sugammadex is a relaxant-binding ...

ANI Pharmaceuticals beat Q4 estimates with strong sales growth and raised its 2025 revenue and EPS outlook, driven by ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

Robert F. Kennedy Jr., our nation’s new Health and Human Services secretary, repeatedly says he wants “gold-standard science.” In my 15 years as a pharmaceutical physician, I oversaw over 200 clinical ...

Nomura has a Buy rating on Cipla after the company's MD reassured that the competitiveness of the Indian generics biz won't ...

Venus Remedies receives marketing authorization for Sugammadex from Philippines: Our Bureau, Mumbai Tuesday, March 4, 2025, 15:40 Hrs [IST] Venus Remedies Limited, a leading India ...

Ever bought a pair of ‘abibas’ slides from Pettah? Or some ‘Colvin Klean’ underwear? No harm if you have (reputational harm ...

The basket acquired, comprises of 13 ANDAs, which are approved by the US Food anf Drugs Administration (US FDA) and 1 ANDA, ...

The Ireland-headquartered Felix Pharmaceuticals, which is eyeing a valuation of around $200-250 million for the controlling ...

A Tebra survey found that 84% of Americans believe generic medications are just as effective as their brand-name counterparts ...